British Columbia is injecting $50 million over two years to expand the availability of nasal naloxone, a critical tool in combating the overdose crisis. Health Minister Josie Osborne announced the initiative, emphasizing its role in saving lives.
This funding means nasal naloxone will constitute roughly half of the over 400,000 naloxone kits distributed annually. The province aims to make these nasal kits accessible at 150 community sites immediately, with distribution broadening to all 2,400 take-home naloxone sites by April.
Injectable naloxone kits have already prevented nearly 40,000 deaths since 2019. Officials state that the increased availability of nasal naloxone will provide a more accessible and user-friendly option, particularly for younger individuals, empowering them to respond effectively in emergencies. This move comes as British Columbia grapples with drug poisoning, a leading cause of death for those aged 10 to 59.
